Tocilizumab for severe COVID-19: a promising intervention affecting inflammation and coagulation.

Categories:
Posted on

Link to article at PubMed

Tocilizumab for severe COVID-19: a promising intervention affecting inflammation and coagulation.

Eur J Intern Med. 2020 May 16;:

Authors: Levi M

PMID: 32425364 [PubMed - as supplied by publisher]

Leave a Reply

Your email address will not be published. Required fields are marked *